Resources

A study reveals that patients with high levels of skin sterol (STC) in combination with high levels of C-reactive protein (hsCRP) are at almost twice the risk of having metabolic syndrome.

The results of the study suggest that metformin should be offered first-line for ovulation induction in all women with PCOS.

A carbohydrate isolated from the liver lowers blood sugar levels after injection.

Low birth weight and a combination of low BMI at 2 years and high BMI at 11 years, reflecting rapid weight gain between age 2 and 11 years, predicts later CHD.

Xenical would be the first of its kind to go from prescription use to pharmacy shelves.

Thirty-six million lives could be saved globally by 2015 if mortality due to chronic diseases fell by an additional 2% annually, according to one of a series of reports in The Lancet.

While some research has found that moderate drinking may protect against diabetes, a new study suggests that other factors may largely explain the seeming benefit.

Very low levels (40 mg/dL) of LDL cholesterol, the so-called “bad” cholesterol, seem to be safe for heart patients who are taking statins.

New treatment provides up to 24-hour duration of action for growing patient population. Detemir®(Insulin Detemir) will be competition for Lantus®

Pargluva® made by Merck and Co. Inc. and Bristol-Myers Squibb, may be delayed in coming to market by 2 years if additional safety studies are required by the FDA.